India · Delayed Price · Currency is INR AstraZeneca Pharma India Statistics
Total Valuation
NSE:ASTRAZEN has a market cap or net worth of INR 210.79 billion. The enterprise value is 205.79 billion.
| Market Cap | 210.79B |
| Enterprise Value | 205.79B |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Jul 18, 2025 |
Share Statistics
| Current Share Class | 25.00M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.14M |
Valuation Ratios
The trailing PE ratio is 114.96.
| PE Ratio | 114.96 |
| Forward PE | n/a |
| PS Ratio | 11.36 |
| PB Ratio | 27.36 |
| P/TBV Ratio | 27.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 112.23 |
| EV / Sales | 11.09 |
| EV / EBITDA | 71.16 |
| EV / EBIT | 83.93 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | n/a |
| Interest Coverage | 118.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 20.13% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 23.13M |
| Profits Per Employee | 2.29M |
| Employee Count | 802 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:ASTRAZEN has paid 628.60 million in taxes.
| Income Tax | 628.60M |
| Effective Tax Rate | 25.53% |
Stock Price Statistics
The stock price has increased by +27.24% in the last 52 weeks. The beta is 0.13, so NSE:ASTRAZEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +27.24% |
| 50-Day Moving Average | 9,015.63 |
| 200-Day Moving Average | 7,943.69 |
| Relative Strength Index (RSI) | 38.12 |
| Average Volume (20 Days) | 28,020 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ASTRAZEN had revenue of INR 18.55 billion and earned 1.83 billion in profits. Earnings per share was 73.33.
| Revenue | 18.55B |
| Gross Profit | 8.21B |
| Operating Income | 2.45B |
| Pretax Income | 2.46B |
| Net Income | 1.83B |
| EBITDA | 2.84B |
| EBIT | 2.45B |
| Earnings Per Share (EPS) | 73.33 |
Balance Sheet
The company has 5.36 billion in cash and 357.30 million in debt, giving a net cash position of 5.00 billion.
| Cash & Cash Equivalents | 5.36B |
| Total Debt | 357.30M |
| Net Cash | 5.00B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 7.70B |
| Book Value Per Share | 308.14 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 44.27%, with operating and profit margins of 13.22% and 9.88%.
| Gross Margin | 44.27% |
| Operating Margin | 13.22% |
| Pretax Margin | 13.27% |
| Profit Margin | 9.88% |
| EBITDA Margin | 15.33% |
| EBIT Margin | 13.22% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 0.38%.
| Dividend Per Share | 32.00 |
| Dividend Yield | 0.38% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -0.05% |
| Shareholder Yield | 0.33% |
| Earnings Yield | 0.87% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |